Project Details
Description
The National Tuberculosis and Leprosy Programme (NTLP) of Tanzania introduced the short treatment regimen for drug-sensitive TB, that includes rifampicin for the full 6 months, in 2006. Realizing that it would not to be able to sustain daily directly observed therapy (DOT) by a health professional, it embarked on a strategy to allow treatment supporters to observe treatment intake outside the direct health system.
The project describes the full cycle of assessing preference of patients, evaluation of the intervention, and monitoring implementation on the ground. CB-DOT is now an integral part of tuberculosis treatment delivery in Tanzania
The project describes the full cycle of assessing preference of patients, evaluation of the intervention, and monitoring implementation on the ground. CB-DOT is now an integral part of tuberculosis treatment delivery in Tanzania
| Acronym | CB-DOT |
|---|---|
| Status | Finished |
| Effective start/end date | 1/11/2005 → 31/12/2012 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
